Appeals court affirmed that SM-102 does not infringe Alnylam’s mRNA patents. The decision supports Moderna’s use of SM-102 in its Spikevax COVID-19 vaccine. Live on Wednesday June 18: 3 Summer ...

Moderna’s Covid shot had previously been approved for people 12 years of age and older regardless of their underlying health.

Moderna's COVID shot had previously been approved for people 12 years of age and older regardless of their underlying health. Vaccine makers have been on high alert to challenges under Kennedy ...

Alnylam lost a similar dispute in a related Moderna case last year. It has filed separate, ongoing patent lawsuits over Pfizer's COVID shots. An Alnylam spokesperson said the company is reviewing ...

Federal health agencies no longer recommend COVID-19 vaccination for healthy children and pregnant women, but older adults now have a new weapon against the virus. Moderna said it has received ...

Moderna Inc. has agreed to do a placebo-controlled trial of its new Covid vaccine that was recently approved by US regulators, Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday.

Moderna (NASDAQ:MRNA) has agreed to conduct another placebo-controlled clinical trial for its newly approved next-gen COVID-19 vaccine, Health and Human Services Secretary Robert F. Kennedy Jr ...

Moderna’s COVID shot had previously been approved for everyone 12 and older. The narrower approval follows the FDA announcing it was likely to limit access to immunizations among healthy ...

01. The Food and Drug Administration approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s existing Covid shot, Spikevax, does not ...